IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 4 Test
At DNA Labs UAE, we offer the IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 4 Test to analyze breast cancer tissue samples. This diagnostic test utilizes immunohistochemistry (IHC) and specific antibodies to detect the presence or absence of certain proteins in breast cancer cells.
Test Components
- ER (Estrogen Receptor)
- PR (Progesterone Receptor)
- HER-2 (Human Epidermal Growth Factor Receptor 2)
- Ki67
- Photomicrograph
- Includes Pathologist review for presence of malignant cells
Price
The cost of the IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 4 Test is 1640.0 AED.
Sample Condition
To ensure accurate results, please submit tumour tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship the sample at room temperature. Additionally, provide a copy of the Histopathology report, indicate the site of biopsy, and provide clinical history.
Report Delivery
Sample: Daily by 6 pm
Block: 5 days
Tissue Biopsy: 5 days
Tissue Large Complex: 7 days
Method
The IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 4 Test utilizes immunohistochemistry as the method of analysis.
Test Type
This test is specifically designed for cancer diagnosis.
Doctor
An oncologist will be responsible for conducting the test.
Test Department
This test is conducted in the Histology department.
Pre Test Information
Please provide a copy of the Histopathology report, indicate the site of biopsy, and provide clinical history.
Test Details
The IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 4 Test is a diagnostic test used to analyze breast cancer tissue samples. It is a type of immunohistochemistry (IHC) test that uses specific antibodies to detect the presence or absence of certain proteins in breast cancer cells.
The panel typically includes four different antibodies that target specific proteins commonly found in breast cancer cells. These proteins can provide important information about the characteristics and behavior of the cancer cells.
The specific antibodies included in the panel may vary depending on the laboratory or institution performing the test. However, some common antibodies used in breast cancer panels include:
- Estrogen Receptor (ER)
- Progesterone Receptor (PR)
- Human Epidermal Growth Factor Receptor 2 (HER2)
- Ki-67
The ER and PR antibodies detect the presence of hormone receptors on breast cancer cells. These receptors indicate whether the cancer cells are dependent on estrogen or progesterone for growth and can help determine appropriate treatment options.
The HER2 antibody detects the presence of the HER2 protein, which is overexpressed in some breast cancers. HER2-positive breast cancers tend to be more aggressive and may require targeted therapies.
The Ki-67 antibody detects a protein associated with cell proliferation. High levels of Ki-67 indicate that the cancer cells are actively dividing and may be more aggressive.
By analyzing the expression of these proteins in breast cancer cells, the IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 4 Test can provide valuable information for diagnosis, prognosis, and treatment planning. The results of the test can help guide personalized treatment decisions and improve patient outcomes.
| Test Name | IMMUNOHISTOCHEMISTRY DIGITAL BREAST CANCER PANEL 4 Test |
|---|---|
| Components | *ER *PR *HER-2 *Ki67 *Photomicrograph*Includes Pathologist review for presence of malignant cells |
| Price | 1640.0 AED |
| Sample Condition | Submit tumour tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report. Indicate site of biopsy and provide Clinical history. |
| Report Delivery | Sample Daily by 6 pm; Report – Block: 5 days Tissue Biopsy: 5 days Tissue Large Complex: 7 days |
| Method | Immunohistochemistry |
| Test type | Cancer |
| Doctor | Oncologist |
| Test Department: | HISTOLOGY |
| Pre Test Information | Provide a copy of the Histopathology report. Indicate site of biopsy and provide Clinical history. |
| Test Details | The Immunohistochemistry Digital Breast Cancer Panel 4 test is a diagnostic test used to analyze breast cancer tissue samples. It is a type of immunohistochemistry (IHC) test that uses specific antibodies to detect the presence or absence of certain proteins in breast cancer cells. The panel typically includes four different antibodies that target specific proteins commonly found in breast cancer cells. These proteins can provide important information about the characteristics and behavior of the cancer cells. The specific antibodies included in the panel may vary depending on the laboratory or institution performing the test. However, some common antibodies used in breast cancer panels include estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67. The ER and PR antibodies detect the presence of hormone receptors on breast cancer cells. These receptors indicate whether the cancer cells are dependent on estrogen or progesterone for growth and can help determine appropriate treatment options. The HER2 antibody detects the presence of the HER2 protein, which is overexpressed in some breast cancers. HER2-positive breast cancers tend to be more aggressive and may require targeted therapies. The Ki-67 antibody detects a protein associated with cell proliferation. High levels of Ki-67 indicate that the cancer cells are actively dividing and may be more aggressive. By analyzing the expression of these proteins in breast cancer cells, the Immunohistochemistry Digital Breast Cancer Panel 4 test can provide valuable information for diagnosis, prognosis, and treatment planning. The results of the test can help guide personalized treatment decisions and improve patient outcomes. |
